Avaleht › Ülekaalulisus › Maryland
Ülekaalulisus kliinilised uuringud osariigis Maryland
37 uuringut haiguse Ülekaalulisus jaoks otsivad osalejaid osariigis Maryland.
Linnad osariigis Maryland
Ametlik uuringutekst (inglise keeles)
Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)
- National Institutes of Health Clinical Center, Bethesda
VärbamineFaas 2Terved vabatahtlikud oodatud
Vanused 18–60 · Naised · Uuendatud 2. okt 2026 · NCT03407079A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Barry J. Reiner, MD LLC, Baltimore
VärbamineFaas 3
Vanused 8–18 · Kõik sood · Uuendatud 30. sept 2026 · NCT07253285Physical and Behavioral Traits of Overweight and Obese Adults
- National Institutes of Health Clinical Center, Bethesda
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 18–100 · Kõik sood · Uuendatud 28. sept 2026 · NCT00428987A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Centennial Medical Group, Columbia
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07794579A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Ascension Saint Agnes Heart Care, Baltimore
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07595549A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Beltsville
- Research Site, Oxon Hill
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT07776509Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Capital Digestive Care - Chevy Chase, Chevy Chase
VärbamineFaas 3
Vanused 18–70 · Kõik sood · Uuendatud 24. sept 2026 · NCT06937099A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Johns Hopkins Children's Center, Baltimore
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 24. sept 2026 · NCT06672549Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Capital Digestive Care - Chevy Chase, Chevy Chase
VärbamineFaas 3
Vanused 18–70 · Kõik sood · Uuendatud 24. sept 2026 · NCT06937086A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Centennial Medical Group, Columbia
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Centennial Medical Group, Columbia
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07392190A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Beltsville
- Research Site, Lanham
- Research Site, Oxon Hill
- ja veel 1
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07784270A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Flourish Research - Bowie, Bowie
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07369011Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Ascension Saint Agnes Heart Care, Baltimore
- MD Medical Research, Oxon Hill
- Velocity Clinical Research - Rockville, Rockville
VärbamineFaas 3
Vanused 45–99 · Kõik sood · Uuendatud 22. sept 2026 · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- MedStar Good Samaritan Hospital, Baltimore
- MedStar Health Research Institute (MedStar Physician Based Research Network), Hyattsville
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07321886Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate
- National Institutes of Health Clinical Center, Bethesda
Värbamine
Vanused 18–65 · Kõik sood · Uuendatud 18. sept 2026 · NCT06044935A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
- Research Site, Brooklyn
VärbamineFaas 1Terved vabatahtlikud oodatud
Vanused 35–75 · Naised · Uuendatud 17. sept 2026 · NCT07013643Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study
- National Institutes of Health Clinical Center, Bethesda
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 12–25 · Kõik sood · Uuendatud 17. sept 2026 · NCT06730113A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Bowie
- AURORA-1 Clinical Site, Rockville
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. sept 2026 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Bowie
- AURORA-2 Clinical Site, Rockville
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. sept 2026 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Centennial Medical Group, Columbia
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 14. sept 2026 · NCT07351058A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Baltimore VA Medical Center, Baltimore
- Johns Hopkins University School of Nursing, Baltimore
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 14. sept 2026 · NCT07351045A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Silver Spring
VärbamineFaas 3Terved vabatahtlikud oodatud
Vanused 18–79 · Kõik sood · Uuendatud 11. sept 2026 · NCT07654374A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity
- PAREXEL Intl - EPCU-Baltimore, Baltimore
VärbamineFaas 1
Vanused 18–55 · Kõik sood · Uuendatud 9. sept 2026 · NCT07566390Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
- Johns Hopkins University, Baltimore
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. sept 2026 · NCT06847399A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Dermatology and Skin Cancer Specialists, LLC, Rockville
VärbamineFaas 4
Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. sept 2026 · NCT06857942Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Annapolis
- Kailera Clinical Site, Columbia
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 3. sept 2026 · NCT07284901Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Columbia
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 3. sept 2026 · NCT07284875Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Silver Spring
VärbamineFaas 3
Vanused 18–79 · Kõik sood · Uuendatud 10. aug 2026 · NCT07654361Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change
- National Institutes of Health Clinical Center, Bethesda
Värbamine
Vanused 18–50 · Kõik sood · Uuendatud 31. juuli 2026 · NCT06325722Healthy for Two-Home Visiting (H42-HV): Health Coaching for Pregnant Women
- Johns Hopkins School of Nursing, Baltimore
Värbamine
Vanused 18 ja vanemad · Naised · Uuendatud 8. juuni 2026 · NCT05619705A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity
- Parexel International-EPCU Baltimore, Baltimore
VärbamineFaas 1/2Terved vabatahtlikud oodatud
Vanused 18–60 · Kõik sood · Uuendatud 2. juuni 2026 · NCT06842186Night Owl Metabolism
- Johns Hopkins School of Medicine, Baltimore
VärbamineTerved vabatahtlikud oodatud
Vanused 18–23 · Kõik sood · Uuendatud 11. mai 2026 · NCT06507722Trial of Food Is Medicine Approaches for Obesity Treatment in Adults With Food Insecurity
- Johns Hopkins University, Baltimore
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. märts 2026 · NCT07396805Metformin IN Asthma for Overweight and Obese Individuals (MINA)
- Johns Hopkins University, Baltimore
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. jaan 2026 · NCT06273072Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors
- Breast Evaluation and Treatment Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore
Värbamine
Kõik vanused · Naised · Uuendatud 23. dets 2025 · NCT07032545Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women
- Pharmaron CPC, Inc, Baltimore
VärbamineFaas 1Terved vabatahtlikud oodatud
Vanused 18–55 · Kõik sood · Uuendatud 6. nov 2025 · NCT07224399Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.